- Journal
- BJU INTERNATIONAL
- Année
- 2006
- Volume
- 98
- Numéro
- 1
- Pages
- 11-19
- Mois
- JUL
- DOI
- 10.1111/j.1464-410X.2006.06177.x
Abstract
In this section there are two reviews concerning prostate cancer, both from the same group of authors. In the first, they describe the combination of nomograms with PSA screening to assess risk and to predict outcomes in the management of prostate cancer. In the second, they indicate how outcomes and quality of life can be optimised in the hormonal treatment of prostate cancer. Botulinum toxin has become very popular in the management of a whole range of conditions both inside and outside the urinary tract. Now it has been extended to prostatic disorders, and the mini-review presented here has evaluated reports and the authors' personal experience in the mechanisms of action and clinical efficacy of Botulinum toxin in the prostate. Finally, there is a mini-review of FISH in bladder cancer, particularly its development, applications, and its potential for the future.